Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID SHUCHIH CHU

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1144260019
CMS profile
324465
Location
NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$1,359.65

58 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,359.65 58

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–58 of 58 matching records. This page contains 8 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID SHUCHIH CHU

NPI 1144260019 · CMS profile ID 324465

Allopathic & Osteopathic Physicians / Ophthalmology

NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–58 of 58 matching records. This page contains 8 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1144260019?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID SHUCHIH CHU, NPI 1144260019, CMS profile ID 324465. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–58 of 58 matching records. This page contains 8 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1144260019?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). DAVID SHUCHIH CHU, NPI 1144260019, CMS profile ID 324465. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–58 of 58 matching records. This page contains 8 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1144260019?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
DAVID SHUCHIH CHU, NPI 1144260019, CMS profile ID 324465, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–58 of 58 matching records. This page contains 8 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1144260019?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

58 matching records · $1,359.65 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 58 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–58 of 58.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $11.9703/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812638441 CMS
Eyevance Pharmaceuticals LLC $14.4503/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807278561 CMS
Novartis Pharmaceuticals Corporation $12.2202/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812638439 CMS
Kala Pharmaceuticals, Inc. $14.5202/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815623401 CMS
Mallinckrodt Hospital Products Inc. $13.4402/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845350855 CMS
Sight Sciences, Inc. $19.6701/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851125495 CMS
Ocular Therapeutix, Inc. $12.8601/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843881899 CMS
Allergan, Inc. $14.9201/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792735607 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $25,710.22 63
PY2020 $5,784.01 38
PY2021 $1,359.65 58
PY2022 $37,864.68 94
PY2023 $12,026.98 63
PY2024 $45,134.05 136
PY2025 $106,453.20 186

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $298,946.06 14
PY2023 Principal investigator $64,500.00 2
PY2022 Principal investigator $240,000.00 1
PY2021 Principal investigator $20,773.00 5
PY2020 Principal investigator $224,940.81 10
PY2019 Principal investigator $131,099.06 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Glaukos Corporation $209.49 12/11/2024 Non-covered Recipient Entity
Amazon.com, Inc.
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785426
Principal investigator 1 Glaukos Corporation $104.55 11/27/2024 Non-covered Recipient Entity
Fisher Scientific
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785410
Principal investigator 1 Glaukos Corporation $104.56 11/27/2024 Non-covered Recipient Entity
Fisher Scientific
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785416
Principal investigator 1 Glaukos Corporation $25.22 11/27/2024 Non-covered Recipient Entity
Lexitas Pharma Services Inc.
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151789005
Principal investigator 1 Glaukos Corporation $348.24 11/13/2024 Non-covered Recipient Entity
OCPC
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785402
Principal investigator 1 Glaukos Corporation $940.05 10/30/2024 Non-covered Recipient Entity
Sherpa Clinical Packaging, LLC
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785414
Principal investigator 1 Glaukos Corporation $33.10 10/23/2024 Non-covered Recipient Entity
Amazon.com, Inc.
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785404
Principal investigator 1 Glaukos Corporation $2,828.70 10/02/2024 Non-covered Recipient Entity
Sherpa Clinical Packaging, LLC
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785430
Principal investigator 1 Glaukos Corporation $57.52 08/28/2024 Non-covered Recipient Entity
Lexitas Pharma Services Inc.
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151789003
Principal investigator 1 Glaukos Corporation $8.13 08/21/2024 Non-covered Recipient Entity
Amazon.com, Inc.
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785394
Principal investigator 1 Mallinckrodt Hospital Products Inc. $90,000.00 08/21/2024 Non-covered Recipient Entity
METROPOLITAN EYE RESEARCH
AN OPEN LABEL, MULTI-CENTERED, RANDOMIZED PHASE 2 STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND BIOACTIVITY OF SUBCUTANEOUS ACTH GEL IN PATIENTS WITH SCLERITIS: THE ATLAS STUDY No dispute reported 06/30/2026 1136893336
Principal investigator 1 Glaukos Corporation $5,913.87 08/07/2024 Non-covered Recipient Entity
Lexitas Pharma Services Inc.
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785400
Principal investigator 1 Glaukos Corporation $3,372.63 06/26/2024 Non-covered Recipient Entity
Sherpa Clinical Packaging, LLC
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151785392
Principal investigator 1 Mallinckrodt Hospital Products Inc. $195,000.00 03/27/2024 Non-covered Recipient Entity
METROPOLITAN EYE RESEARCH
AN OPEN LABEL, MULTI-CENTERED, RANDOMIZED PHASE 2 STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND BIOACTIVITY OF SUBCUTANEOUS ACTH GEL IN PATIENTS WITH SCLERITIS: THE ATLAS STUDY No dispute reported 06/30/2026 1136893310